3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
4
Prostatic Neoplasms
2
Bile Duct Neoplasms
2
Vulvar Neoplasms
1
Sarcoma
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Hereditary Sensory and Autonomic Neuropathies
1
Gallbladder Neoplasms
1
Disease Progression
1
Clear-cell metastatic renal cell carcinoma
1
Cholangiocarcinoma
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Interventions
Injections
20
Carboplatin
9
pembrolizumab
8
Bevacizumab
6
Pemetrexed
5
Paclitaxel
5
Leucovorin
5
Fluorouracil
5
fludarabine
4
Oxaliplatin
4
Docetaxel
4
sotorasib
3
atezolizumab
3
Drug Therapy
3
Cyclophosphamide
3
Capecitabine
3
trifluridine tipiracil drug combination
2
trametinib
2
toripalimab
2
spartalizumab
2
palbociclib
2
olaparib
2
Panitumumab
2
Immune Checkpoint Inhibitors
2
Fulvestrant
2
Etoposide
2
Cisplatin
2
Cetuximab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
tivozanib
×
1 year
×
Clear all
No trials found.